Gradually increasing pacing impedances with normal sensing values in pacemaker and defibrillation leads: A watchful waiting strategy
Heart Rhythm · 2026
DOI: 10.1016/j.hrthm.2025.08.033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Heart Rhythm, 2026. Verfasst von Eva Roseboom und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: e.roseboom@um…. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Pacemaker, Artificial, Cardiac Pacing, Artificial, Arrhythmias, Cardiac. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hartstichting, ZonMw, Bayer.
Abstract (Originalsprache)
BACKGROUND: The increasing prevalence of cardiac implantable electronic devices (CIEDs) has led to greater data collection, including pacing impedance, a key measure of lead integrity and electrical function. Although acute impedance changes may signal lead fractures or insulation defects, gradual increases are often linked to tissue-interface calcification. The optimal management of patients with progressively rising impedance remains uncertain. OBJECTIVE: This study aimed to assess the prevalence, clinical consequences, and management strategies for CIED leads showing a gradual increase in pacing impedance of >1200 Ω. METHODS: We conducted a single-center retrospective cohort study of 59 patients (42 with an implantable cardioverter-defibrillator and 17 with a pacemaker) over a median follow-up of 9.2 years (range 2.8-18.5). Data on patient demographics, device characteristics, and outcomes associated with elevated impedance were analyzed. Impedance values, intracardiac signals, and pacing thresholds were assessed at baseline and every 6 months up to 18 years. RESULTS: Among patients with an implantable cardioverter-defibrillator, 33 of 42 leads (78.6%) were preserved, whereas 9 were replaced (5 prophylactically, 2 owing to oversensing, and 2 for threshold issues). In patients with a pacemaker, 12 of 17 leads (70.6%) were preserved, with 5 replacements (4 prophylactic and 1 for threshold issues). CONCLUSION: A watchful waiting strategy seems safe for patients without sensing or threshold concerns and in the absence of a pacing indication. A patient-centered approach should guide the management of gradual impedance increases in CIED leads.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: e.roseboom@umcg.nl.
- Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Department of Cardiology, Isala Hospital, Zwolle, The Netherlands.
- Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Förderung
- Hartstichting
- ZonMw
- Bayer
- Horizon 2020 Framework Programme
- Ministerie van Volksgezondheid, Welzijn en Sport
Zitieren
APA
Roseboom, E., Daniëls, F., Klingenberg, M. G., Groenveld, H. F., Mulder, B. A., Rienstra, M., & Maass, A. H. (2026). Gradually increasing pacing impedances with normal sensing values in pacemaker and defibrillation leads: A watchful waiting strategy. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2025.08.033
Vancouver
Roseboom E, Daniëls F, Klingenberg MG, Groenveld HF, Mulder BA, Rienstra M, et al. Gradually increasing pacing impedances with normal sensing values in pacemaker and defibrillation leads: A watchful waiting strategy. Heart Rhythm. 2026. doi:10.1016/j.hrthm.2025.08.033
BibTeX
@article{Roseboom2026,
author = {Roseboom, Eva and Daniëls, Fenna and Klingenberg, Martijn G and Groenveld, Hessel F and Mulder, Bart A and Rienstra, Michiel and Maass, Alexander H},
title = {Gradually increasing pacing impedances with normal sensing values in pacemaker and defibrillation leads: A watchful waiting strategy},
journal = {Heart Rhythm},
year = {2026},
doi = {10.1016/j.hrthm.2025.08.033}
}
EUVIMED